Drug Shortage Report for APO-PERINDOPRIL-INDAPAMIDE
| Report ID | 184092 |
| Drug Identification Number | 02297574 |
| Brand name | APO-PERINDOPRIL-INDAPAMIDE |
| Common or Proper name | PERINDOPRIL-INDAPAMIDE |
| Company Name | APOTEX INC |
| Market Status | MARKETED |
| Active Ingredient(s) | INDAPAMIDE PERINDOPRIL ERBUMINE |
| Strength(s) | 1.25MG 4MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30 BLS |
| ATC code | C09BA |
| ATC description | ACE INHIBITORS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-07 |
| Estimated end date | 2023-09-22 |
| Actual end date | 2023-09-15 |
| Shortage status | Resolved |
| Updated date | 2023-09-22 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
| Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v45 | 2023-09-22 | French | Compare |
| v44 | 2023-09-22 | English | Compare |
| v43 | 2023-09-07 | French | Compare |
| v42 | 2023-09-07 | English | Compare |
| v41 | 2023-09-01 | French | Compare |
| v40 | 2023-09-01 | English | Compare |
| v39 | 2023-08-04 | French | Compare |
| v38 | 2023-08-04 | English | Compare |
| v37 | 2023-07-21 | French | Compare |
| v36 | 2023-07-21 | English | Compare |
| v35 | 2023-07-21 | English | Compare |
| v34 | 2023-07-13 | French | Compare |
| v33 | 2023-07-13 | English | Compare |
| v32 | 2023-07-07 | French | Compare |
| v31 | 2023-07-07 | English | Compare |
| v30 | 2023-06-29 | French | Compare |
| v29 | 2023-06-29 | English | Compare |
| v28 | 2023-06-23 | French | Compare |
| v27 | 2023-06-23 | English | Compare |
| v26 | 2023-06-23 | French | Compare |